Cargando…
Myeloid Leukemia of Down Syndrome
SIMPLE SUMMARY: Patients with Down Syndrome have been thoroughly studied over the past 100 years, and many attempts have been made to attain insight into the developmental biology of DS. Given the association of DS with several hematological disorders, it was more than appealing to us to conduct a l...
Autores principales: | Kosmidou, Aikaterini, Tragiannidis, Athanasios, Gavriilaki, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340042/ https://www.ncbi.nlm.nih.gov/pubmed/37444375 http://dx.doi.org/10.3390/cancers15133265 |
Ejemplares similares
-
Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
por: Karpa, Vasiliki, et al.
Publicado: (2023) -
The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
por: Moser, Bernhard, et al.
Publicado: (2021) -
Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas
por: Kyriakidis, Ioannis, et al.
Publicado: (2022) -
Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report
por: Tragiannidis, Athanasios, et al.
Publicado: (2011) -
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
por: Gavriilaki, Eleni, et al.
Publicado: (2020)